← All Sponsors
SPONSOR

Zuoyi Jiao

Total Trials
1
Recruiting
1
Phases
Phase 3

Zuoyi Jiao is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Gastric Cancer (Including Stomach and Gastroesophageal Junction [GEJ]), Neoadjuvant Therapy, Adjuvant Chemotherapy, pCR Rate.

The trial portfolio spans Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Zuoyi Jiao

How many clinical trials has Zuoyi Jiao sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Zuoyi Jiao, of which 1 are actively recruiting participants. These trials cover conditions including Gastric Cancer (Including Stomach and Gastroesophageal Junction [GEJ]), Neoadjuvant Therapy, Adjuvant Chemotherapy. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Zuoyi Jiao research focus on?
Zuoyi Jiao clinical trials span Gastric Cancer (Including Stomach and Gastroesophageal Junction [GEJ]), Neoadjuvant Therapy, Adjuvant Chemotherapy, pCR Rate, MPR, and additional conditions. The research pipeline includes Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Zuoyi Jiao clinical trial?
To participate in a Zuoyi Jiao trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Zuoyi Jiao trials with current recruitment status updated daily.

Clinical Trials by Zuoyi Jiao

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology